Ruxolitinib Reduces Oxidative Stress in Patients With Primary Myelofibrosis: A Multicenter Study
Author:
Publisher
Cureus, Inc.
Subject
Aerospace Engineering
Reference24 articles.
1. Primary myelofibrosis: 2021 update on diagnosis, risk-stratification and management;Tefferi A;Am J Hematol,2021
2. Blast phase myeloproliferative neoplasm: Mayo-AGIMM study of 410 patients from two separate cohorts;Tefferi A;Leukemia,2018
3. Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases;Mesa RA;Blood,2005
4. Mutations and prognosis in primary myelofibrosis;Vannucchi AM;Leukemia,2013
5. JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis;Harrison C;N Engl J Med,2012
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Assessment of Total Antioxidant Capacity, 8-Hydroxy-2′-deoxy-guanosine, the Genetic Landscape, and Their Associations in BCR::ABL-1-Negative Chronic and Blast Phase Myeloproliferative Neoplasms;International Journal of Molecular Sciences;2024-06-17
2. Targeted Metabolomics Highlights Dramatic Antioxidant Depletion, Increased Oxidative/Nitrosative Stress and Altered Purine and Pyrimidine Concentrations in Serum of Primary Myelofibrosis Patients;Antioxidants;2024-04-19
3. Acute myocardial infarction in myeloproliferative neoplasms;World Journal of Cardiology;2023-11-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3